Honey Reddi, PhD, FACMG

Honey Reddi, PhD, FACMG is a distinguished clinical genomics leader with over 35 years of experience in laboratory genetics and translational genomics. She currently serves as Chief Laboratory Officer at Belay Diagnostics, where she oversees complex laboratory operations, strategic partnerships, and clinical assay development. Dr. Reddi’s expertise spans operational excellence in CLIA- and CAP-accredited laboratories across both academic and industry settings, with a particular focus on precision medicine and clinically actionable genomic diagnostics for complex diseases such as CNS tumors.

Prior to her current role, Dr. Reddi held senior leadership positions including Professor and Chief of the Division of Clinical Genomics at the Medical College of Wisconsin, and Senior Vice President and Medical Director at Belay Diagnostics. Earlier in her career, she led translational research programs on thyroid cancer at the Mayo Clinic, where she combined her strong foundation in biotechnology and molecular genetics with innovative clinical applications. Her work reflects a rare ability to bridge cutting-edge genomic research with real-world clinical impact, driving both patient-centered outcomes and scientific discovery.

Dr. Reddi has been widely recognized for her contributions to science, education, and leadership. She has received numerous honors, including the Outstanding Graduate Educator Award (Medical College of Wisconsin, 2023) and the Women of Innovation Award (Connecticut Technology Council, 2018). She is an active member of leading professional societies, including the American College of Medical Genetics and Genomics, the Association for Molecular Pathology, and the Clinical and Laboratory Standards Institute, and contributes regularly to national committees and working groups on laboratory quality and innovation. Fluent in English and Telugu, with professional proficiency in Hindi and Tamil, Dr. Reddi remains deeply committed to mentorship, education, and advancing the field of clinical genomics to improve patient care worldwide.

• Jamia Hamdard University – PhD, Biotechnology
• Osmania University – Master of Science, Microbiology
• Osmania University – Bachelor of Science, Genetics, Botany, and Chemistry
• Mayo Clinic Alix School of Medicine – ABMGG Fellowship, Clinical Molecular Genetics
• Medical College of Wisconsin – ABMGG Fellowship, Clinical Cytogenetics

• American Board of Medical Genetics and Genomics (ABMGG) – Clinical Molecular Genetics
• American Board of Medical Genetics and Genomics (ABMGG) – Laboratory Genetics and Genomics
• Certificate of Qualification – Genetic Testing
• Certificate of Qualification – Oncology
• RPVI: Registered Physician in Vascular Interpretation

• Outstanding Graduate Educator Award
• Women of Innovation Award
• Nominee & Finalist, WIT Woman of the Year, Women in Thyroidology, American Thyroid Association
• Young Investigator Award
• Basic Research Fellow Award
• Best Scientific Abstract and Poster
• National Fellowship for Advanced Training in Molecular Biology
• Gregor Mendel Award for Highest Cumulative Score in Genetics

• American College of Medical Genetics and Genomics
• Association for Molecular Pathology
• American Society for Clinical Pathology
• Clinical and Laboratory Standards Institute
• Cancer Genetics Consortium
• American Society for Human Genetics
• American Association for Cancer Research
• American Virology Association
• American Thyroid Association

• Teacher, Mayo Outreach to Students and Teachers (MOST) program, Rochester Public Schools